Company

CellVax Therapeutics, Inc.

Biotechnology Research 1951 Nw 7th Ave 2 employees

Employees: 2
Contacts: 1
Emails: 1
Phones: 1

www.cellvx.com LinkedIn Crunchbase

CellVax Therapeutics, Inc. Overview

Headquarters: 1951 Nw 7th Ave
Website: www.cellvx.com
Industry: Biotechnology Research
Employees: 2
Founded: 2020
Funding: 2.1M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Cell-based Therapy Solid Tumors Autologous Vaccine MHC II FK-PC101 Prostate Cancer Prostate Cancer Vaccine Immunotherapy

About CellVax Therapeutics, Inc.

CellVax Therapeutics is a privately-held clinical-stage company active in research, development, and innovation on individualized cell-based immunotherapies. CellVax Therapeutics has developed a proprietary personalized tumor cell-based cancer immuno-therapy platform. The company has completed Phase I and Phase II clinical trial in Brazil and has initiated (Oct 24) a Phase II Adaptive Design Trial for patients with high-risk prostate cancer. https://clinicaltrials.gov/study/NCT06636682